Hershey CEO Kirk Tanner told investors Thursday that retail sales for Ice Breakers grew more than 8% in the first quarter, attributing part of the growth to “functional snacking tailwinds, including GLP-1 adoption.” CNBC framed the disclosure around so-called Ozempic breath, the unofficial side effect linked to dehydration and changes in saliva that some users report. Hershey’s Q1 was otherwise strong: net sales rose 10.6% to $3.1 billion, North America salty snacks grew 26%, and protein bar sales climbed 17%.
The mint disclosure is the one worth pulling apart. Hershey did not say GLP-1 adoption caused the Ice Breakers lift. The framing was that the category benefits from functional snacking tailwinds, and GLP-1 adoption is one of them. CNBC noted directly that Tanner did not specify why GLP-1 use was driving the gum and mint category. That distinction governs how Walmart suppliers should read the news. It is not an argument that confection has been redefined. It is a signal that one corner of confection has acquired a functional use case the buyer can write up.
Ice Breakers, by Hershey’s own ranking on the call, is its third-largest confection brand. At Walmart, mints and gum live primarily at the front end. The candy aisle is where Hershey’s, Reese’s, and Jolly Rancher do their work, all of which posted strong non-seasonal lifts in the quarter on their own merits, with Hershey’s and Reese’s up 11% and 10% respectively per Tanner’s prepared remarks. The GLP-1 commentary does not travel to those brands. It travels to a fixture set that has been under sustained pressure as impulse occasions migrate elsewhere in the store.
That changes the conversation a 1P confection supplier should be having heading into the next line review. A GLP-1 use case for breath-freshening gum and mints is, in shelf terms, an argument for defending or expanding front-end facings rather than candy-aisle linear feet. The April 16 announcement that Walmart has expanded its Better Care Services platform to include weight management support for customers on or exploring GLP-1 therapies, with prescriptions filled across nearly 4,600 pharmacies, means a meaningful share of Walmart’s footfall now intersects with GLP-1 adherence at the pharmacy counter. The customer walking from the pharmacy to the parking lot is the customer Tanner was describing.
The same April 16 announcement included a redesigned GLP-1 destination on Walmart.com. The page is live and currently leads with a Zepbound from LillyDirect placement starting at $299, available for in-store pickup. The three categories Walmart has chosen to feature underneath are Protein, Digestive Care, and Vitamins, with sub-categories for nausea and constipation surfaced under the digestive header. None of the featured categories on the destination page surface breath products, gum, or mints.
That gap is the Walmart-specific signal worth reading. Hershey is claiming a GLP-1 tailwind for Ice Breakers based on retail sales data, while Walmart’s own merchandising team has not built the digital shelf adjacency that would amplify it. For 1P confection suppliers, that is an opening, not a refutation. The functional argument for mints at the front end exists in retail sales data. It does not yet exist in Walmart’s curated GLP-1 browse experience. Suppliers entering their next JBP or category review with Hershey’s number in hand should be ready to show the buyer where the adjacency could live, including on Walmart.com, not assume it is already accounted for.
The phrase Tanner used, functional snacking tailwinds, is the more durable one for suppliers to internalize. Hershey is not the only company drawing the line. The Magnum Ice Cream Company also reported Q1 results today, and CEO Peter ter Kulve told analysts that growth in the U.S. is being driven by consumers shifting from bulk ice cream into handheld premium and healthier variants, adding that “GLP-1 strengthens this trend.” When two large CPG companies call out the same dynamic across two different categories on the same day, that is not noise. It is a pattern Walmart suppliers should expect to encounter in next-quarter line reviews regardless of category.
The underlying mechanic is the GLP-1 user’s narrowed consideration set. KFF’s November 2025 Health Tracking Poll found about 1 in 8 U.S. adults, roughly 12%, were currently taking a GLP-1, double the 6% reported in May 2024, and Cornell University research in the Journal of Marketing Research found GLP-1 households cut grocery spending 5.3% within six months of starting. When eating occasions contract and basket size shrinks, the items that survive are the ones with a functional reason to be in the basket. For a Walmart JBP, that means the operative question is no longer whether GLP-1 shoppers are a segment to chase. It is which of a supplier’s SKUs has a functional argument the buyer can defend on the planogram.
For 1P confection suppliers selling into Walmart U.S., the immediate read is that the front-end story and the candy-aisle story are now diverging. Front-end mints and gum can be merchandised against a functional benefit story that did not exist eighteen months ago. Candy-aisle confection still rises and falls on tentpole programming, seasonal lifts, and pricing. Hershey credited March Madness as the Reese’s tentpole and prior Olympics campaign activity for Hershey’s brand momentum in the quarter, not any health repositioning.
For 3P Marketplace sellers, the implication is different. Sellers in adjacent functional categories, including sugar-free mints, dry-mouth lozenges, electrolyte products, fiber and protein supplements, are competing for the same search adjacencies that GLP-1 shoppers will increasingly key into through Walmart’s destination page. The featured shelves on that page are currently protein, digestive care, and vitamins. Sellers whose listings can be discovered through those browse paths sit closer to the GLP-1 shopper than sellers in adjacent niches that the page does not currently surface. That is governed by content, claims discipline, and search relevance rather than by line review.
CNBC reported Hershey shares were down more than 2% in morning trading despite the beat, the salty snacks acceleration, and the GLP-1 disclosure. The market is not yet pricing functional snacking as a structural lift to confection. The buyer conversation a Walmart supplier should be preparing reflects the same caution: one quarter of mint growth with a GLP-1 caveat earns a fixture-level argument, not a category one.